Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Benefitfocus Expands Its Ecosystem To Offer Employers the Health E(fx) ACA Platform

PR Newswire December 5, 2014

ProNAi Reports Significant Activity and Ongoing Durable Responses in Relapsed or Refractory Non-Hodgkin's Lymphoma with PNT2258

Canada NewsWire December 5, 2014

IRCM researchers identify a protein that controls the "guardian of the genome" - A study sheds new light on a well-known mechanism required for the immune response

Canada NewsWire December 5, 2014

Onconova Therapeutics to Host Analyst Event in New York City on December 12, 2014

GlobeNewswire December 5, 2014

Champions Oncology Closes Convertible Debt Financing

PR Newswire December 5, 2014

Nubity Inc. Launches Hybrid Cloud Management Tool on the IBM Cloud

PR Newswire December 5, 2014

Pharmacyclics Announces Launch of informCLL(TM) Registry for Chronic Lymphocytic Leukemia (CLL) Patients

PR Newswire December 5, 2014

Cornerstone Pharmaceuticals Commences Phase I Clinical Trial of CPI-613 for the Treatment of B-Cell Non-Hodgkin Lymphoma

GlobeNewswire December 5, 2014

Cellular Research Launches Precise(TM) Targeted RNASeq Assays

PR Newswire December 5, 2014

Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing

Canada NewsWire December 5, 2014

Cannabis Science (CBIS) Readies To Launch New Products In California With Apothocary Genetics

PR Newswire December 5, 2014

RxAir Device Destroys Flu Viruses Missed By Vaccines

Marketwired December 5, 2014

Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire December 5, 2014

QLT Announces Results From Proof-of-Concept Trial With Oral Synthetic cis-Retinoid (QLT091001) in Adult Subjects With Impaired Dark Adaptation and/or Impaired Low Luminance Vision

GlobeNewswire December 5, 2014

Stemline Therapeutics Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting

GlobeNewswire December 5, 2014

Jinko Solar 'Eagle+' Modules Reach the New Height of Power Output for 60-cell Multi c-Si Module

PR Newswire December 5, 2014

Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award

PR Newswire December 5, 2014

Say Goodbye to Coughs, Colds and Sneezes With AirCon Safe

PR Newswire December 5, 2014

World should be skeptical of China's announcement to end organ harvesting from executed prisoners by January 1, 2015

PR Newswire December 5, 2014

Emery Oleochemicals' Natural-based Solutions Designed to Safeguard the Future of Bees, Credited as 'Non-toxic'

PR Newswire December 5, 2014